Menu Back to Marketing-Pharmaceuticals-2016

Overview

March 2, 2016 - Tutorial (PM)*
March 3-4, 2016 - Conference

*Tutorials require registration and are an additional fee


Now in its 27th year, the DIA Marketing Pharmaceuticals 2016 Planning Team created a program that celebrates the conference components you look forward to each year while INCREASING the number of varied content offerings, INTRODUCING new interactive session formats, and providing MORE structured networking opportunities. 

This conference is designed for professionals working through regulatory and compliance challenges in the marketing, advertising, and promotion of pharmaceuticals, veterinary products, biologics, and medical devices.


NEW Conference Features:

  • Attend a DIA Advertising and Promotion Working Group (APWG) Meeting – meet members from DIA’s Regulatory Affairs Ad Promo community and learn how to get involved on March 2, 5:15-6:30PM.
  • DIA Mobile App – keep connected throughout the conference and engage in session polls
  • Round Table Discussion Luncheon – conversations inspired by sessions and led by community leaders on March 4, 11:30AM-1:00PM.
  • Poster Presentations –  view poster presentations throughout the conference
  • More Interactive Sessions – learn from industry experts and from each other through panel and audience discussion


“Why Do I Attend DIA’s Marketing Pharmaceuticals Conference?” Top 5 Responses from Attendee Survey. TO:

  1. interact with OPDP leadership and personnel
  2. network with my industry colleagues and meet current and future clients
  3. participate in a Live information exchange between industry and government on best practice trends and issues
  4. learn the latest industry best practices and guidelines
  5. earn ACPE and IACET credits

Featured topics

  • FDA updates on recent enforcement actions and guidances
  • Litigation
  • Compliance updates
  • Safety labeling changes: real world execution into packaging, advertising, and promotion
  • Engaging payors, nontraditional, and emerging customer markets
  • Advocacy groups: when & how should they be engaged?
  • How to remain compliant in a global environment
  • Scientific exchange
  • Social media: using new and emerging technologies compliantly
  • Global advertising and promotion processes and standards

Who should attend?

Professionals in pharmaceutical, biologics, and medical device companies involved in:

  • Regulatory Affairs
  • Marketing
  • Communications
  • Compliance
  • Medical Information and Affairs
  • Legal
  • Senior Management

Learning objectives

At the conclusion of this conference, participants should be able to:

  • Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
  • Examine the compliance challenges companies face, including how to evaluate challenges, and factors to consider that may impact the development of solutions
  • Discuss the best US and global review and approval practices
  • Describe promotional and non-promotional tactics trending in the pharmaceutical industry that require thoughtful regulatory review
  • Analyze effective digital and social media strategies designed to meet the challenges of ensuring compliance with FDA regulatory requirements

Program Committee

  • Thomas W. Abrams, MBA, RPh
    Thomas W. Abrams, MBA, RPh Director, Office of Prescription Drug Promotion, OMP, CDER
    FDA, United States
  • Glenn N. Byrd, MBA, RAC
    Glenn N. Byrd, MBA, RAC Senior Director, Specialty Care Promotional Regulatory Affairs
    Astrazeneca, United States
  • Dale  Cooke
    Dale Cooke Owner
    PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos VP and Head, US Specialty Care 2, North America and Global Regulatory Affairs  
    Sanofi US, United States
  • Lynette  Hopkinson
    Lynette Hopkinson Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
    Vertex Pharmaceuticals Incorporated, United States
  • John T. Murray
    John T. Murray President
    Grayscale Compliance LLC, United States
  • Wayne L. Pines
    Wayne L. Pines President, Regulatory Services and Healthcare
    APCO Worldwide Inc., United States
  • Lucy  Rose, MBA
    Lucy Rose, MBA President
    Lucy Rose and Associates, LLC, United States
  • Kristina  Vlaovic, MPH
    Kristina Vlaovic, MPH Vice President, Regulatory, Safety and Pharmacovigilance
    HALOZYME Inc., United States
Load More

Contact us


Registration Questions?

Send Email
1.888.257.6457
+1.215.442.6100


Agenda Details

Send Email
+1.215.442.6117


Event Logistics

Send Email
+1.215.293.5816


Exhibit Information

Send Email
+1.215.442.6184